Advancements in the development of nucleic acid vaccines for syphilis prevention and control.

Li, Sijia; Li, Weiwei; Jin, Yinqi; Wu, Bin; Wu, Yimou

Li, Sijia; Li, Weiwei; Jin, Yinqi; Wu, Bin; Wu, Yimou.

Afiliação

Li S; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China.
Li W; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China.
Jin Y; Department of Clinical Laboratory, The Second People's Hospital of Foshan, Foshan, China.
Wu B; Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College, Institution of Pathogenic Biology, University of South China, Hengyang, China.
Wu Y; First Affiliated Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China.

Hum Vaccin Immunother ; 19(2): 2234790, 2023 08 01.

Article em En | MEDLINE | ID: mdl-37538024

Assuntos

COVID-19; Sífilis; Humanos; Sífilis/prevenção & controle; Sífilis/epidemiologia; Vacinas Baseadas em Ácido Nucleico; Treponema pallidum/genética; Penicilinas

Palavras-chave

DNA vaccine; Treponema pallidum; mRNA vaccines; syphilis; traditional vaccines

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: Sífilis / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google